Nupenta Tablet

• Acidity
  
• Treatment of Heartburn
  
• Gastroesophageal reflux disease (Acid reflux)
  
• Peptic ulcer disease
  
• Treatment of Zollinger-Ellison syndrome
  

Most side effects of Nupenta Tablet do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

Common side effects include:

• Vomiting
• Nausea
  
• Diarrhea
  
• Abdominal pain
  
• Flatulence
  
• Headache
  

• The dosage and duration of the Nupenta Tablet are decided by the doctor based on the severity of the condition and other health factors.
• Take this tablet on an empty stomach for better results. Before starting this medicine, please inform your doctor about your medical history.
• If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.​
  

Nupenta Tablet is contains active ingredient Pantoprazole (40mg) which is a proton pump inhibitor (PPI). It works by reducing the amount of acid in the stomach which helps in relief of acid related indigestion & heartburn.

It irreversibly block the action of H+/K+-ATPase enzyme that is a proton pump, in the stomach's parietal cells which results in effectively blocking the final step of acid production and significantly lowering stomach acidity.

• Röhss, K., Lind, T., & Wilder-Smith, C. (2004). Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. European journal of clinical pharmacology, 60(8), 531-539.
  
• Poole, P. (2001). Pantoprazole. American journal of health-system pharmacy, 58(11), 999-1008.
  
• Van Rensburg, C. J., Honiball, P. J., Grundling, H. D., Van Zyl, J. H., Spies, S. K., Eloff, F. P., ... & Bethke, T. D. (1996). Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. Alimentary pharmacology & therapeutics, 10(3), 397-401.
  
• Dias, L. M. (2009). Pantoprazole: a proton pump inhibitor. Clinical drug investigation, 29(Suppl 2), 3-12.
  
• Scholten, T., Gatz, G., & Hole, U. (2003). Once‐daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD‐related symptoms. Alimentary pharmacology & therapeutics, 18(6), 587-594.
  
• Tutuian, R., Katz, P. O., Bochenek, W., & Castell, D. O. (2002). Dose‐dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Alimentary pharmacology & therapeutics, 16(4), 829-836.​